These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
151 related articles for article (PubMed ID: 21974923)
1. Targeted therapy of SMMC-7721 liver cancer in vitro and in vivo with carbon nanotubes based drug delivery system. Ji Z; Lin G; Lu Q; Meng L; Shen X; Dong L; Fu C; Zhang X J Colloid Interface Sci; 2012 Jan; 365(1):143-9. PubMed ID: 21974923 [TBL] [Abstract][Full Text] [Related]
2. Folate-mediated poly(3-hydroxybutyrate-co-3-hydroxyoctanoate) nanoparticles for targeting drug delivery. Zhang C; Zhao L; Dong Y; Zhang X; Lin J; Chen Z Eur J Pharm Biopharm; 2010 Sep; 76(1):10-6. PubMed ID: 20472060 [TBL] [Abstract][Full Text] [Related]
3. Effect of intratumoral injection on the biodistribution and therapeutic potential of novel chemophor EL-modified single-walled nanotube loading doxorubicin. Liu H; Xu H; Wang Y; He Z; Li S Drug Dev Ind Pharm; 2012 Sep; 38(9):1031-8. PubMed ID: 22794192 [TBL] [Abstract][Full Text] [Related]
4. A hepatocellular carcinoma-specific adenovirus variant, CV890, eliminates distant human liver tumors in combination with doxorubicin. Li Y; Yu DC; Chen Y; Amin P; Zhang H; Nguyen N; Henderson DR Cancer Res; 2001 Sep; 61(17):6428-36. PubMed ID: 11522637 [TBL] [Abstract][Full Text] [Related]
5. Cucumber mosaic virus as drug delivery vehicle for doxorubicin. Zeng Q; Wen H; Wen Q; Chen X; Wang Y; Xuan W; Liang J; Wan S Biomaterials; 2013 Jun; 34(19):4632-42. PubMed ID: 23528229 [TBL] [Abstract][Full Text] [Related]
6. Enriching lipid nanovesicles with short-chain glucosylceramide improves doxorubicin delivery and efficacy in solid tumors. van Lummel M; van Blitterswijk WJ; Vink SR; Veldman RJ; van der Valk MA; Schipper D; Dicheva BM; Eggermont AM; ten Hagen TL; Verheij M; Koning GA FASEB J; 2011 Jan; 25(1):280-9. PubMed ID: 20876209 [TBL] [Abstract][Full Text] [Related]
7. Targeted delivery and controlled release of doxorubicin to cancer cells using modified single wall carbon nanotubes. Zhang X; Meng L; Lu Q; Fei Z; Dyson PJ Biomaterials; 2009 Oct; 30(30):6041-7. PubMed ID: 19643474 [TBL] [Abstract][Full Text] [Related]
8. Tumor cells-specific targeting delivery achieved by A54 peptide functionalized polymeric micelles. Du YZ; Cai LL; Liu P; You J; Yuan H; Hu FQ Biomaterials; 2012 Dec; 33(34):8858-67. PubMed ID: 22959183 [TBL] [Abstract][Full Text] [Related]
9. Improved therapeutic effect of DOX-PLGA-PEG micelles decorated with bivalent fragment HAb18 F(ab')(2) for hepatocellular carcinoma. Jin C; Qian N; Zhao W; Yang W; Bai L; Wu H; Wang M; Song W; Dou K Biomacromolecules; 2010 Sep; 11(9):2422-31. PubMed ID: 20831277 [TBL] [Abstract][Full Text] [Related]
10. Galactosylated chitosan-grafted multiwall carbon nanotubes for pH-dependent sustained release and hepatic tumor-targeted delivery of doxorubicin in vivo. Qi X; Rui Y; Fan Y; Chen H; Ma N; Wu Z Colloids Surf B Biointerfaces; 2015 Sep; 133():314-22. PubMed ID: 26123852 [TBL] [Abstract][Full Text] [Related]
11. Targeted and pH-responsive delivery of doxorubicin to cancer cells using multifunctional dendrimer-modified multi-walled carbon nanotubes. Wen S; Liu H; Cai H; Shen M; Shi X Adv Healthc Mater; 2013 Sep; 2(9):1267-76. PubMed ID: 23447549 [TBL] [Abstract][Full Text] [Related]
12. Peptide-conjugated PAMAM for targeted doxorubicin delivery to transferrin receptor overexpressed tumors. Han L; Huang R; Liu S; Huang S; Jiang C Mol Pharm; 2010 Dec; 7(6):2156-65. PubMed ID: 20857964 [TBL] [Abstract][Full Text] [Related]
13. Folate-conjugated PEG on single walled carbon nanotubes for targeting delivery of Doxorubicin to cancer cells. Niu L; Meng L; Lu Q Macromol Biosci; 2013 Jun; 13(6):735-44. PubMed ID: 23616476 [TBL] [Abstract][Full Text] [Related]
14. In vitro and in vivo antitumor effects of doxorubicin loaded with bacterial magnetosomes (DBMs) on H22 cells: the magnetic bio-nanoparticles as drug carriers. Sun JB; Duan JH; Dai SL; Ren J; Zhang YD; Tian JS; Li Y Cancer Lett; 2007 Dec; 258(1):109-17. PubMed ID: 17920762 [TBL] [Abstract][Full Text] [Related]
15. Dual targeted delivery of doxorubicin to cancer cells using folate-conjugated magnetic multi-walled carbon nanotubes. Lu YJ; Wei KC; Ma CC; Yang SY; Chen JP Colloids Surf B Biointerfaces; 2012 Jan; 89():1-9. PubMed ID: 21982868 [TBL] [Abstract][Full Text] [Related]
16. Novel folated and non-folated pullulan bioconjugates for anticancer drug delivery. Scomparin A; Salmaso S; Bersani S; Satchi-Fainaro R; Caliceti P Eur J Pharm Sci; 2011 Apr; 42(5):547-58. PubMed ID: 21371555 [TBL] [Abstract][Full Text] [Related]
17. Improved therapeutic activity of folate-targeted liposomal doxorubicin in folate receptor-expressing tumor models. Gabizon A; Tzemach D; Gorin J; Mak L; Amitay Y; Shmeeda H; Zalipsky S Cancer Chemother Pharmacol; 2010 May; 66(1):43-52. PubMed ID: 19779718 [TBL] [Abstract][Full Text] [Related]
18. Carbon nanotube lipid drug approach for targeted delivery of a chemotherapy drug in a human breast cancer xenograft animal model. Shao W; Paul A; Zhao B; Lee C; Rodes L; Prakash S Biomaterials; 2013 Dec; 34(38):10109-19. PubMed ID: 24060420 [TBL] [Abstract][Full Text] [Related]
19. The performance of doxorubicin encapsulated in chitosan-dextran sulphate microparticles in an osteosarcoma model. Tan ML; Friedhuber AM; Dunstan DE; Choong PF; Dass CR Biomaterials; 2010 Jan; 31(3):541-51. PubMed ID: 19836833 [TBL] [Abstract][Full Text] [Related]
20. Thermo-sensitive liposomes loaded with doxorubicin and lysine modified single-walled carbon nanotubes as tumor-targeting drug delivery system. Zhu X; Xie Y; Zhang Y; Huang H; Huang S; Hou L; Zhang H; Li Z; Shi J; Zhang Z J Biomater Appl; 2014 Nov; 29(5):769-79. PubMed ID: 25033825 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]